Related Experiment Video
Updated: Mar 31, 2026

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
Synthetic SiRNA Delivery: Progress and Prospects.
Thomas C Roberts1,2,3, Kariem Ezzat2, Samir El Andaloussi2,4
1Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA, 92037, USA.
Small interfering RNA (siRNA) offers therapeutic potential by silencing target genes. Overcoming delivery challenges is key to its use in treating diseases via RNA interference (RNAi).
Area of Science:
- Biotechnology
- Molecular Biology
- Pharmacology
Background:
- Small interfering RNA (siRNA) mediates gene expression modulation through RNA interference (RNAi).
- siRNA's ability to silence target gene transcripts offers therapeutic potential for various diseases.
- Systemic in vivo delivery of siRNA is hindered by poor drug-likeness, physiological barriers, and toxicity concerns.
Purpose of the Study:
- To review and discuss strategies for overcoming the challenges of systemic siRNA delivery.
- To highlight advancements in making siRNA a viable pharmaceutical agent.
Main Methods:
- Chemical modification of siRNA molecules.
- Conjugation of siRNA to bioactive moieties.
- Development of nanoparticle formulations for siRNA delivery.
Main Results:
- Various chemical modifications enhance siRNA stability and reduce off-target effects.
- Bioactive conjugations improve siRNA targeting and cellular uptake.
- Nanoparticle formulations protect siRNA from degradation and facilitate systemic delivery.
Conclusions:
- siRNA delivery strategies are crucial for realizing its therapeutic potential.
- Chemical modifications, bioactive conjugations, and nanoparticle formulations represent promising approaches to enable effective in vivo siRNA therapy.
- Continued research in siRNA delivery is essential for developing novel treatments for a wide range of diseases.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Microorganisms in Medicine and Therapeutics

